Retatrutide Cardiovascular and Kidney Outcomes Study in Obesity | Retatrutide News

The TRIUMPH-Outcomes study is investigating retatrutide's effects on cardiovascular and kidney outcomes in obese adults. The trial will last about five ...
Clinical Trials · October 28, 2026